387 related articles for article (PubMed ID: 8552081)
1. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2.
Yang BS; Hauser CA; Henkel G; Colman MS; Van Beveren C; Stacey KJ; Hume DA; Maki RA; Ostrowski MC
Mol Cell Biol; 1996 Feb; 16(2):538-47. PubMed ID: 8552081
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.
Galang CK; García-Ramírez J; Solski PA; Westwick JK; Der CJ; Neznanov NN; Oshima RG; Hauser CA
J Biol Chem; 1996 Apr; 271(14):7992-8. PubMed ID: 8626480
[TBL] [Abstract][Full Text] [Related]
4. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
5. The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1.
Bosselut R; Duvall JF; Gégonne A; Bailly M; Hémar A; Brady J; Ghysdael J
EMBO J; 1990 Oct; 9(10):3137-44. PubMed ID: 2209540
[TBL] [Abstract][Full Text] [Related]
6. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
8. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
9. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
[TBL] [Abstract][Full Text] [Related]
10. ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation.
Sgouras DN; Athanasiou MA; Beal GJ; Fisher RJ; Blair DG; Mavrothalassitis GJ
EMBO J; 1995 Oct; 14(19):4781-93. PubMed ID: 7588608
[TBL] [Abstract][Full Text] [Related]
11. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
12. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene.
Wu H; Moulton K; Horvai A; Parik S; Glass CK
Mol Cell Biol; 1994 Mar; 14(3):2129-39. PubMed ID: 8114743
[TBL] [Abstract][Full Text] [Related]
14. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
Galang CK; Der CJ; Hauser CA
Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
[TBL] [Abstract][Full Text] [Related]
16. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.
McCarthy SA; Chen D; Yang BS; Garcia Ramirez JJ; Cherwinski H; Chen XR; Klagsbrun M; Hauser CA; Ostrowski MC; McMahon M
Mol Cell Biol; 1997 May; 17(5):2401-12. PubMed ID: 9111309
[TBL] [Abstract][Full Text] [Related]
17. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
18. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.
Jayaraman G; Srinivas R; Duggan C; Ferreira E; Swaminathan S; Somasundaram K; Williams J; Hauser C; Kurkinen M; Dhar R; Weitzman S; Buttice G; Thimmapaya B
J Biol Chem; 1999 Jun; 274(24):17342-52. PubMed ID: 10358095
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression.
Langer SJ; Bortner DM; Roussel MF; Sherr CJ; Ostrowski MC
Mol Cell Biol; 1992 Dec; 12(12):5355-62. PubMed ID: 1448070
[TBL] [Abstract][Full Text] [Related]
20. Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro.
Hevér A; Oshima RG; Hauser CA
Exp Cell Res; 2003 Oct; 290(1):132-43. PubMed ID: 14516794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
